Avedro Initiates Keraflex(R) KXL Clinical Trials for Treating Keratoconus

WALTHAM, Mass.--(BUSINESS WIRE)--During the 5th International Congress of Corneal Cross Linking for Keratoconus in Leipzig, Germany on December 5th, Avedro presented encouraging early clinical results for treating keratoconus, a progressive disease of the cornea of the eye. The procedure, known as Keraflex® KXL, is non-incisional and reshapes the cornea without removing any tissue.
MORE ON THIS TOPIC